These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18627547)

  • 1. Upstream oversight assessment for agrifood nanotechnology: a case studies approach.
    Kuzma J; Romanchek J; Kokotovich A
    Risk Anal; 2008 Aug; 28(4):1081-98. PubMed ID: 18627547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology, risk, and oversight: learning lessons from related emerging technologies.
    Kuzma J; Priest S
    Risk Anal; 2010 Nov; 30(11):1688-98. PubMed ID: 20723152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated approach to oversight assessment for emerging technologies.
    Kuzma J; Paradise J; Ramachandran G; Kim JA; Kokotovich A; Wolf SM
    Risk Anal; 2008 Oct; 28(5):1197-220. PubMed ID: 18631303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to responsible innovation of nanotechnology applications in food and agriculture: A study of US experts and developers.
    Cummings CL; Kuzma J; Kokotovich A; Glas D; Grieger K
    NanoImpact; 2021 Jul; 23():100326. PubMed ID: 35559827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications and implications of nanotechnologies for the food sector.
    Chaudhry Q; Scotter M; Blackburn J; Ross B; Boxall A; Castle L; Aitken R; Watkins R
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Mar; 25(3):241-58. PubMed ID: 18311618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating oversight systems for emerging technologies: a case study of genetically engineered organisms.
    Kuzma J; Najmaie P; Larson J
    J Law Med Ethics; 2009; 37(4):546-86. PubMed ID: 20122100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology and its applications in the food sector.
    Sozer N; Kokini JL
    Trends Biotechnol; 2009 Feb; 27(2):82-9. PubMed ID: 19135747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology risk perceptions and communication: emerging technologies, emerging challenges.
    Pidgeon N; Harthorn B; Satterfield T
    Risk Anal; 2011 Nov; 31(11):1694-700. PubMed ID: 22084861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived risks and perceived benefits of different nanotechnology foods and nanotechnology food packaging.
    Siegrist M; Stampfli N; Kastenholz H; Keller C
    Appetite; 2008 Sep; 51(2):283-90. PubMed ID: 18406006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational safety and health's role in sustainable, responsible nanotechnology: gaps and needs.
    Iavicoli S; Rondinone BM; Boccuni F
    Hum Exp Toxicol; 2009 Jun; 28(6-7):433-43. PubMed ID: 19755456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are environmental regulations keeping up with innovation? A case study of the nanotechnology industry.
    Fairbrother A; Fairbrother JR
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1327-30. PubMed ID: 19423165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterial health effects--Part 2: Uncertainties and recommendations for the future.
    Powell MC; Kanarek MS
    WMJ; 2006 May; 105(3):18-23. PubMed ID: 16749320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying food proteins with allergenic potential: evolution of approaches to safety assessment and research to provide additional tools.
    Ladics GS; Selgrade MK
    Regul Toxicol Pharmacol; 2009 Aug; 54(3 Suppl):S2-6. PubMed ID: 19028539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of health safety aspects of nanotechnologies in food production.
    Bouwmeester H; Dekkers S; Noordam MY; Hagens WI; Bulder AS; de Heer C; ten Voorde SE; Wijnhoven SW; Marvin HJ; Sips AJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):52-62. PubMed ID: 19027049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Biology in the FDA Realm: Toward Productive Oversight Assessment.
    Fatehi L; Hall RF
    Food Drug Law J; 2015; 70(2):339-69, iii-iv. PubMed ID: 26302603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurosurgery in the realm of 10(-9), Part 2: applications of nanotechnology to neurosurgery--present and future.
    Elder JB; Liu CY; Apuzzo ML
    Neurosurgery; 2008 Feb; 62(2):269-84; discussion 284-5. PubMed ID: 18382306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will nanotechnology make the world a better place?
    Parr D
    Trends Biotechnol; 2005 Aug; 23(8):395-8. PubMed ID: 15967522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foresight Study on the Risk Governance of New Technologies: The Case of Nanotechnology.
    Read SA; Kass GS; Sutcliffe HR; Hankin SM
    Risk Anal; 2016 May; 36(5):1006-24. PubMed ID: 26332140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnological medical devices and nanopharmaceuticals: the European regulatory framework and research needs.
    Rickerby DG
    J Nanosci Nanotechnol; 2007 Dec; 7(12):4618-25. PubMed ID: 18283854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. South African farm workers' interpretation of risk assessment data expressed as pictograms on pesticide labels.
    Rother HA
    Environ Res; 2008 Nov; 108(3):419-27. PubMed ID: 18755451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.